<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04586868</url>
  </required_header>
  <id_info>
    <org_study_id>95428</org_study_id>
    <nct_id>NCT04586868</nct_id>
  </id_info>
  <brief_title>VR-assisted CBT for Adolescents With Psychosis</brief_title>
  <official_title>VR-assisted Cognitive Behaviour Therapy for Adolescents With Psychosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Helse Stavanger HF</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Haukeland University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Psychotic disorders typically emerge during late adolescence or early adulthood. Patients,&#xD;
      who are diagnosed with a psychotic disorder before turning 18 years, are defined as early&#xD;
      onset psychosis patients (EOP). Relative to adult patients, these patients show a worse&#xD;
      long-term prognoses. Social impairment present a major barrier towards recovery, and thus and&#xD;
      important issue to address in treatment. Cognitive behavioral therapy (CBT) is the&#xD;
      recommended psychological treatment for psychotic disorders. As part of the therapy, the&#xD;
      patient does an exposure-based training in a social environment. This type of training has&#xD;
      several limitations for patients with psychosis. The last decade there has been a growing&#xD;
      interest in using virtual reality (VR) to understand and treat various psychological&#xD;
      disorders. There is a lack of research on VR-interventions for EOP patients. This study will&#xD;
      assess the acceptability, tolerability, feasibility and clinical efficacy of a novel&#xD;
      VR-assisted CBT interventions for adolescents with psychosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study adhere to the model for research made by the international Virtual Reality&#xD;
      Clinical Outcomes Research Experts groups (VR-CORE). The study consist of three sub-studies.&#xD;
      First a qualitative study assessing the acceptability for VR among adolescence with&#xD;
      psychosis. Secondly, a randomized study of the feasibility of virtual reality environment for&#xD;
      adolescents with psychosis. Third, assessing the clinical efficacy of a novel VR-assisted CBT&#xD;
      interventions for adolescents with psychosis, through a non-randomized single-case study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">July 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acceptability for a virtual reality intervention</measure>
    <time_frame>5 months</time_frame>
    <description>Semi-structured interview</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Social self-efficacy</measure>
    <time_frame>1 week before, and 10 minutes after treatment.</time_frame>
    <description>Adolescent self-efficacy scale (S-EFF)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Social interaction and social phobia</measure>
    <time_frame>1 week before, and 10 minutes after treatment.</time_frame>
    <description>Short Form Social Interaction Anxiety Scale/Social Phobia Scale (SIAS-6/SPS-6)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Social paranoia</measure>
    <time_frame>1 week before and 1 week after treatment.</time_frame>
    <description>State Social Paranoia Scale (SSPS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-esteem</measure>
    <time_frame>1 week before, and 10 minutes after treatment.</time_frame>
    <description>Rosenberg Self-Esteem scale (RSES)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychotic symptoms</measure>
    <time_frame>1 week before and 1 week after treatment.</time_frame>
    <description>Brief Psychiatric Rating Scale (BPRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The experience of presence</measure>
    <time_frame>10 minutes after treatment</time_frame>
    <description>Gatineau Presence Questionnaire (GPQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unwanted side effect</measure>
    <time_frame>10 minutes before and 10 minutes after treatment</time_frame>
    <description>Virtual Reality Sickness Questionnaire (VRSQ)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Level of functioning</measure>
    <time_frame>1 week after treatment.</time_frame>
    <description>Children's Global Assessment Scale (C-GAS)</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Psychotic Disorders</condition>
  <arm_group>
    <arm_group_label>A psychotic disorder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients, age 13-18 years old, diagnosed with a psychotic disorder (WHO ICD-10 )</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>An intervention development study</intervention_name>
    <description>Assessing the acceptability for a virtual reality intervention among adolescents with psychosis</description>
    <arm_group_label>A psychotic disorder</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>A randomized feasibility study</intervention_name>
    <description>Feasibility of virtual reality environment for adolescents with psychosis</description>
    <arm_group_label>A psychotic disorder</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>A single-case study</intervention_name>
    <description>The clinical efficacy of a novel VR-assisted CBT interventions for adolescents with psychosis</description>
    <arm_group_label>A psychotic disorder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Suffering from a psychotic disorder (ICD-10 WHO)&#xD;
&#xD;
          -  In stable clinical condition (i.e. not hospitalized)&#xD;
&#xD;
          -  Being able to speak Norwegian or a Scandinavian language, or English&#xD;
&#xD;
          -  Able to provide informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Primary neurological or endocrinological disorder&#xD;
&#xD;
          -  Started a &quot;transfer-process&quot; to Department of Adult Psychiatry.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Irene Elgen, phd</last_name>
    <role>Study Director</role>
    <affiliation>Haukeland University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guri-Elise Holgersen, MA</last_name>
    <phone>004790737908</phone>
    <email>guri-elise.holgersen@helse-bergen.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Irene Elgen, phd</last_name>
    <phone>004791550904</phone>
    <email>irene.bircow.elgen@helse-bergen.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Haukeland university hospital</name>
      <address>
        <city>Bergen</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irene Elgen, phd</last_name>
      <phone>004791550904</phone>
      <email>irene.bircow.elgen@helse-bergen.no</email>
    </contact>
    <contact_backup>
      <last_name>Guri-Elise Holgersen, MA</last_name>
      <phone>004790737908</phone>
      <email>guri-elise.holgersen@helse-bergen.no</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 16, 2020</study_first_submitted>
  <study_first_submitted_qc>October 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 14, 2020</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Psychosis</keyword>
  <keyword>Adolescents</keyword>
  <keyword>Virtual Reality treatment</keyword>
  <keyword>Cognitive Behavioural Therapy</keyword>
  <keyword>Early onset psychosis</keyword>
  <keyword>VR-assisted therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychotic Disorders</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

